Arkolith/Insider Trading/NKTR/Form 4

Robin Howard W

President & CEO, DirectorNEKTAR THERAPEUTICS (NKTR) · full profile →Form 4 · filed Sep 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$311K
Net Open-Market Flow
-$311K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 9, 2025Sell(S)2K$45.16$95K54K
Sep 9, 2025Sell(S)1K$46.41$56K53K
Sep 9, 2025Sell(S)2K$47.49$102K51K
Sep 9, 2025Sell(S)1K$48.18$58K49K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-114365) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML